Author(s): Ramsaneh Raghuwanshi, Hemendra P. Singh


DOI: 10.5958/0974-360X.2021.00053.6   

Address: Ramsaneh Raghuwanshi*, Hemendra P. Singh
Research Scholar, Faculty of Pharmacy, Bhupal Nobles University, Udaipur, Rajasthan.
*Corresponding Author

Published In:   Volume - 14,      Issue - 1,     Year - 2021

Prolonged hyperglycemia often associated with the number of complications such as diabetic neuropathy, retinopathy, nephropathy, cardiomyopathy etc. Diabetic neuropathy is damage to nerves in the body that occurs due to high blood glucose level. In the central nervous system, diabetes exacerbates depression, phobias, anorexia, hypolocomotion, anxiety, cognitive dysfunction etc. The design, docking and analysis of novel arylidine malononitrile-based molecules as derivatives as peroxisome proliferator-activated receptor-? (PPAR-?) modulators for antidiabetic activity are reported. Docking studies of designed compounds were carried out using GLIDE (Grid-based ligand docking with emergetics) module version 4.5, Schrodinger, LLC, Newyork, NY,2007. The software package running on multi-processor Linux PC. GLIDE has previously been validated& applied successfully to predict the binding orientation of many ligands. Docking studies of compounds were performed using human peroxisomes proliferators activated receptor gamma (PDB ID 2PRG) obtained from the RCSB Protein Data Bank. Different arylidine malononitrile derivatives were docked into the ligand binding domain of PPAR-? by the Glide XP module of Schrodinger, out of those Eight derivatives (AM01, AM02, AM03, AM04, AM05, AM06, AM07, AM08) having Glide XP scores?>?-9 as compared to the standard drug, rosiglitazone (Glide XP score?=?-8.34), showed almost similar interaction with the amino acids such as SER-289, GLN-286, and HIE-323 in the molecular docking studies.

Cite this article:
Ramsaneh Raghuwanshi, Hemendra P. Singh. Docking Analysis of Novel Arylidinemalononitrile derivatives as PPAR-γ Modulators in the Management of type II Diabetes Mellitus. Research J. Pharm. and Tech. 2021; 14(1):295-299. doi: 10.5958/0974-360X.2021.00053.6

Ramsaneh Raghuwanshi, Hemendra P. Singh. Docking Analysis of Novel Arylidinemalononitrile derivatives as PPAR-γ Modulators in the Management of type II Diabetes Mellitus. Research J. Pharm. and Tech. 2021; 14(1):295-299. doi: 10.5958/0974-360X.2021.00053.6   Available on:

1.    Shaw, J.E., R.A. Sicree, and P.Z. Zimmet: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes research and clinical practice 2010; 87(1): p. 4-14.
2.    Danaei, G., et al.: National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2· 7 million participants. The Lancet, 2011; 378(9785): p. 31-40.
3.    Nwauche, Kelechi Thank God, Monago, C.C., Anacletus, F.C. Management of Diabetic Induced Hyperlipidemia with Combined Therapy of Reducdyn and Metformin in Streptozotocin Induced Diabetic Male Rats. Research J. Pharm. and Tech. 7(8): August 2014 Page 910-91.
4.    Surendra Nath Pandeya, Rajeev Kumar, Arun Kumar, Ashish Kumar Pathak. Antidiabetics Review on Natural Products. Research J. Pharm. and Tech. 3(2): April- June 2010; Page300-318.
5.    S. Subramanian, S. Rajeswari, G. Sriram Prasath. Antidiabetic, Antilipidemic and Antioxidant Nature of Tridax procumbens Studied in Alloxan-Induced Experimental Diabetes in Rats: a Biochemical Approach. Asian J. Research Chem. 4(11): Nov., 2011; Page 1732-1738.
6.    Monago C.C., Amachree I., Joshua P.E. Diabinese and Nicotinic acid Combination Reduced Cardiovascular Indices in Experimental DiabetesAsian J. Research Chem. 3(3): July- Sept. 2010; Page 785-790.
7.    Samidha Kamtekar, Vrushali Keer. Management of Diabetes: A Review. Research J. Pharm. and Tech. 7(9): Sept. 2014 Page 1065-1072.
8.    K. Radhika, B. Kumaravel, V. Thamizhiniyan, S. Subramanian. Biochemical evaluation of antidiabetic activity of Piper betel leaves extract in alloxan-induced diabetic rats. Asian J. Research Chem. 6(1): January 2013; Page 76-82.
9.    Swathi N, Subrahmanyam CVS, Satyanarayana K. Synthesis and Quantitative Structure-Antioxidant Activity Relationship Analysis of Thiazolidine-2,4-dione Analogues. Asian J. Research Chem 8(1): January 2015; Page 21-26
10.    Suresh Kumar Sutrakar, Drutpal Singh Baghel. Biochemical Parameters Variations in Type–II Diabetes Mellitus: Special Reference in Rewa Region. Asian J. Research Chem. 7(10): October- 2014; Page 877-881.
11.    Lustman, P.J., L.S. Griffith, and R.E. Clouse: Depression in adults with diabetes: results of 5-yr follow-up study. Diabetes care 1988; 11(8): p. 605-612.
12.    Nouwen, A., et al.: Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes a systematic review and meta-analysis of the European Depression in Diabetes (EDID) research consortium. Diabetes care 2011; 34(3): p. 752-762.
13.    Patel, S.S., A. Parashar, and M. Udayabanu: Urtica dioica leaves modulates muscarinic cholinergic system in the hippocampus of streptozotocin-induced diabetic mice. Metabolic brain disease 2015; 30(3): p. 803-811.
14.    Lupien, S.B., E.J. Bluhm, and D.N. Ishii: Systemic insulin‐like growth factor‐I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning/memory in normal adult rats. Journal of neuroscience research 2003; 74(4): p. 512-523.
15.    Egede, L.E. and C. Ellis: Diabetes and depression: global perspectives. Diabetes research and clinical practice 2010; 87(3): p. 302-312.
16.    Pipatpiboon, N., et al.: PPARγ agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets. Endocrinology 2011; 153(1): p. 329-338.
17.    Patel, S.S., S. Gupta, and M. Udayabanu: Urtica dioica modulates hippocampal insulin signaling and recognition memory deficit in streptozotocin induced diabetic mice. Metabolic brain disease 2016; 31(3): p. 601-611.
18.    Greene-Schloesser, D., et al.: The peroxisomal proliferator-activated receptor (PPAR) α agonist, fenofibrate, prevents fractionated whole-brain irradiation-induced cognitive impairment. Radiation research 2014; 181(1): p. 33-44.
19.    PB Suruse, A Roy, KR Kakade, VB Mathur, MK Kale. Clinical Study of Marketed Ayurvedic Preparation in Diabetic Induced Stress. Research J. Pharm. and Tech. 1(4): Oct.-Dec. 2008; Page 414-417.
20.    Sandip N. Badeliya, Dhrubo Jyoti Sen. Bioreceptor Platform: A Macromolecular Bed for Drug Design. Asian J. Research Chem. 3(4): Oct. - Dec. 2010; Page 812-820.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available